Detection of potential safety signals related to the use of remdesivir and tocilizumab in the COVID era during pregnancy, resorting to open data from the FDA adverse event reporting system (FAERS)

Overview of attention for article published in Frontiers in Pharmacology, January 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Dimensions has found 2 publications that cite this research output.

Article in Congenital Anomalies (July 2024)

Article in Heliyon (May 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.